These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25565769)

  • 1. Impact of crystal polymorphism on the systemic bioavailability of rifaximin, an antibiotic acting locally in the gastrointestinal tract, in healthy volunteers.
    Blandizzi C; Viscomi GC; Scarpignato C
    Drug Des Devel Ther; 2015; 9():1-11. PubMed ID: 25565769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is generic rifaximin still a poorly absorbed antibiotic? A comparison of branded and generic formulations in healthy volunteers.
    Blandizzi C; Viscomi GC; Marzo A; Scarpignato C
    Pharmacol Res; 2014 Jul; 85():39-44. PubMed ID: 24836868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of multiple-dose, oral rifaximin on the pharmacokinetics of intravenous and oral midazolam in healthy volunteers.
    Pentikis HS; Connolly M; Trapnell CB; Forbes WP; Bettenhausen DK
    Pharmacotherapy; 2007 Oct; 27(10):1361-9. PubMed ID: 17896891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rifaximin, a poorly absorbed antibiotic: pharmacology and clinical potential.
    Scarpignato C; Pelosini I
    Chemotherapy; 2005; 51 Suppl 1():36-66. PubMed ID: 15855748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic study of rifaximin after oral administration in healthy volunteers.
    Descombe JJ; Dubourg D; Picard M; Palazzini E
    Int J Clin Pharmacol Res; 1994; 14(2):51-6. PubMed ID: 7836025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High gastrointestinal permeability and local metabolism of naringenin: influence of antibiotic treatment on absorption and metabolism.
    Orrego-Lagarón N; Martínez-Huélamo M; Vallverdú-Queralt A; Lamuela-Raventos RM; Escribano-Ferrer E
    Br J Nutr; 2015 Jul; 114(2):169-80. PubMed ID: 26083965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailability of two oral formulations of a single dose of levofloxacin 500 mg: an open-label, randomized, two-period crossover comparison in healthy Mexican volunteers.
    Galan-Herrera JF; Poo JL; Rosales-Sanchez O; Fuentes-Fuentes E; Cariño L; Burke-Fraga V; Namur S; Parra MG
    Clin Ther; 2009 Aug; 31(8):1796-803. PubMed ID: 19808138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic pharmacokinetics of rifaximin in volunteers with shigellosis.
    Taylor DN; McKenzie R; Durbin A; Carpenter C; Haake R; Bourgeois AL
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1179-81. PubMed ID: 18086855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioavailability and pharmacokinetic comparison between generic and branded azithromycin capsule: a randomized, double-blind, 2-way crossover in healthy male Thai volunteers.
    Boonleang J; Panrat K; Tantana C; Krittathanmakul S; Jintapakorn W
    Clin Ther; 2007 Apr; 29(4):703-10. PubMed ID: 17617293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biologic properties and clinical uses of rifaximin.
    DuPont HL
    Expert Opin Pharmacother; 2011 Feb; 12(2):293-302. PubMed ID: 21226639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioavailability of two sublingual formulations of ketorolac tromethamine 30 mg: a randomized, open-label, single-dose, two-period crossover comparison in healthy Mexican adult volunteers.
    Galán-Herrera JF; Poo JL; Maya-Barrios JA; de Lago A; Oliva I; González-de la Parra M; Jiménez P; López-Bojórquez E; Burke-Fraga V; Namur S
    Clin Ther; 2008 Sep; 30(9):1667-74. PubMed ID: 18840372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic comparisons between two formulations containing 100 mg of miglitol in healthy male Korean volunteers: a randomized, open-label, single-dose, two-period, two-sequence crossover bioequivalence study.
    Choi HG; Jeon JY; Im YJ; Kim Y; Jang H; Kang S; Kim KH; Chae SW; Lee SY; Kim MG
    Int J Clin Pharmacol Ther; 2014 Jan; 52(1):55-63. PubMed ID: 24290415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A bioavailability/bioequivalence and pharmacokinetic study of two oral doses of torasemide (5 and 10 mg): prolonged-release versus the conventional formulation.
    Barbanoj MJ; Ballester MR; Antonijoan RM; Puntes M; Gropper S; Santos B; Albet C; Guglietta A
    Clin Exp Pharmacol Physiol; 2009 May; 36(5-6):469-77. PubMed ID: 19673928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rifaximin: An Antibiotic with Important Biologic Effects.
    DuPont HL
    Mini Rev Med Chem; 2015; 16(3):200-5. PubMed ID: 26202192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative bioavailability of single-dose methylphenidate from a multilayer-release bead formulation and an osmotic system: a two-way crossover study in healthy young adults.
    Reiz JL; Donnelly GA; Michalko K
    Clin Ther; 2008 Jan; 30(1):59-69. PubMed ID: 18343243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of food on the pharmacokinetics of rifalazil, a novel antibacterial, in healthy male volunteers.
    Chen YX; Cabana B; Kivel N; Michaelis A
    J Clin Pharmacol; 2007 Jul; 47(7):841-9. PubMed ID: 17463218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative bioavailability and pharmacokinetics of investigational enteric- and film-coated formulations of flurbiprofen 100-mg tablets: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Pakistani male volunteers.
    Ahmad M; Pervaiz F
    Clin Ther; 2010 Mar; 32(3):607-13. PubMed ID: 20399997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomised, two-period, cross-over, open-label study to evaluate the pharmacokinetic profiles of single doses of two different flurbiprofen 8.75-mg lozenges in healthy volunteers.
    Matzneller P; Burian A; Martin W; Annoni O; Lauro V; Tacchi R; Brunner M; Zeitlinger M
    Pharmacology; 2012; 89(3-4):188-91. PubMed ID: 22433300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An open-label, two-period, crossover study of the systemic bioavailability in healthy women of clindamycin phosphate from two vaginal cream formulations.
    Levinson RS; Mitan SJ; Steinmetz JI; Gattermeir DJ; Schumacher RJ; Joffrion JL
    Clin Ther; 2005 Dec; 27(12):1894-900. PubMed ID: 16507375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.